Investors in TauRx Pharma have exercised warrants worth around $119 million, adding to the biotech's financial resources as it prepares regulatory filings for tau-targeting Alzheimer's drug ...

Eli Lilly is still celebrating the FDA approval of its amyloid-directed Alzheimer's therapy Kisunla but has had less fortune with a candidate against tau, another well-established drug target for the ...

If you're wondering when a particular codex released during 9th edition 40k, check out our guide to 9th edition codexes. The Drukhari marks the last codex confirmed for 10th edition, but we're still ...